Effects of Garston Tool and Neuromuscular Reeducation in Cervical Headache

Health Education Research Foundation (HERF)30 enrolled

Overview

Patients suffering from Cervicogenic headache have restricted range of motion and pain which in turn causes functional disability and reduced quality of life. The aim of this research was to determine the effects of Graston technique to improve range of motion, function, and reduction of pain and in patients having Cervicogenic headache

A randomized controlled trial in which Graston Technique and Neuromuscular Re-education technique would be applied on patients presenting with cervicogenic headaches by using different tools and the changes would be examined pre and post intervention. The participants fulfilling inclusion criteria would be randomly allocated to two groups. Both groups received different protocols and will be assessed on data collection tool on their first and last visit using Goniometer, Headache Disability Index (HDI), Neck pain Disability Index (NDI) and Numeric Pain Rating Scale (NPRS). Participants of both groups will be pre-tested before the application of interventional techniques and post-tested after the application of respective intervention.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Cervicogenic Headache

Interventions

Garston toolDEVICE

GT group protocol included the use application of IASTM along with the application of ice therapy at the end of the session. Using the Graston instrument, 20 strokes per minute proximal to distal and 20 strokes per minute distal to proximal for a period of 3 minutes were given over the painful area. Baseline values were recorded for demographics evaluation and episodes of pain onsets. The assessment of patients was done at the initial and last visit before the completion of the treatment program. Three treatment sessions per week were given to each patient for a total of four weeks.

Neuromuscular Re-educationPROCEDURE

General stretching and strengthening exercises for the neck muscles. The protocol of treatment for the NMR group included the use of the Neuromuscular re-education soft tissue mobilization technique (NMR) followed by active movements of the patient.

Eligibility

Sex: ALLMin age: 20 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age: Minimum 20years- Maximum 50 years (Male/Female) * Unilateral pain * Neck stiffness and ROM restrictions * Pain exacerbated by posture and neck movements * Pain effecting QOL * Positive flexion-rotation test Exclusion Criteria: * Headache not of cervical origin * Congenital condition of cervical spine * Headache with autonomic involvement, dizziness or visual impairment * Inability to tolerate the flexion rotation test * Conditions contraindicated for graston technique

Locations (1)

Nazma

Islamabad, Pakistan

Outcomes

Primary Outcomes

Change from Baseline in pain on 10 points on Numeric Pain Rating Scale at 4th week

The Numeric Pain Rating Scale, is a validated, self reported tool assessing average pain intensity over period of last 24 hours. Possible pain ranges from 0( No pain) to 10 (Worst pain). Change= (Week 4 Score - Baseline Score )

Time frame: Baseline and 4th week

Change from Baseline in pain on 27 items on Headache Disability Index at 4th week

Headache Disability Index is a 27 items questionnaire that identify the limitations experienced due to headache. It includes questions to identify the frequency ranges from one per month, more than one but less than four per months, more than one per week and intensity of headache ranges from mild to moderate and to severe.

Time frame: Baseline and 4th week

Change from Baseline in pain on 10 items on Neck Disability Index at 4th week

Neck Pain Disability Index is a 10 items questionnaire that identify the functional status of patients based on their conditions. it includes questions related to pain, personal care, reading, lifting, headaches, driving, sleeping , work, focus and leisure.

Time frame: Baseline and 4th week

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.